Longieva Therapeutics
June 16, 2025
Start-Up Stadium
North Lobby
Company Description: Development of New Generation Selective Cannabinoid Receptor 2 Agonists for Substance Use Disorders
Company HQ City:
Palo Alto, CA 94304
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2023
CEO
Dr. Mehrdad Shamloo
Website
na
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}